News

News
Partner news

ESCAPE Bio Closes $73 Million in Crossover Financing to Advance Clinical Development of Precision Neurology Medicines for Genetic Neurodegeneration

Read full story
Partner news

Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease

Read full story
Press release

Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration

Read full story
Press release

Johnson & Johnson Innovation and Janssen Announce the Awardees of the World Without Disease Call-for-Proposal

Read full story
Partner news

GI Windows Raises $16.4M in Series A-1 Financing

Read full story
Partner news

Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases

Read full story
Partner news

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

Read full story
Partner news

Thirty Madison Raises $47M in Series B Financing From Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc. and Existing Investors

Read full story
Partner news

ViaCyte and Gore Enter Clinical Phase Agreement Based on Novel Membrane Technology for PEC-Encap Product Candidate

Read full story
In the media

Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine

Read full story
In the media

Driving Innovation In UK Life Sciences

Read full story
Partner news

Vor Biopharma Closes $110 Million Series B Financing

Read full story
Partner news

CVRx Raises $50 Million in New Equity Financing

Read full story
In the media

Investing in innovation – new digital approaches for a new decade

Read full story
Partner news

Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test

Read full story